about
Chronic bacterial prostatitis: efficacy of short-lasting antibiotic therapy with prulifloxacin (Unidrox®) in association with saw palmetto extract, lactobacillus sporogens and arbutin (Lactorepens®)Salvage radical prostatectomy after external beam radiation therapy: a systematic review of current approachesImpact of novel techniques on minimally invasive adrenal surgery: trends and outcomes from a contemporary international large series in urology.No increase in toxicity of pelvic irradiation when intensity modulation is employed: clinical and dosimetric data of 208 patients treated with post-prostatectomy radiotherapyLocal staging of penile cancer using magnetic resonance imaging with pharmacologically induced penile erection.Low serum total testosterone level as a predictor of upstaging and upgrading in low-risk prostate cancer patients meeting the inclusion criteria for active surveillance.Prostate Health Index (Phi) and Prostate Cancer Antigen 3 (PCA3) significantly improve prostate cancer detection at initial biopsy in a total PSA range of 2-10 ng/mlRadiotherapy in Prostate Cancer Patients With Pelvic Lymphocele After Surgery: Clinical and Dosimetric Data of 30 Patients.Metachronous bladder metastases from renal cell carcinoma: a case report and review of the literature.The incidence and relative risk of cardiovascular toxicity in patients treated with new hormonal agents for castration-resistant prostate cancer.Is there still a role for sorafenib in metastatic renal cell carcinoma? A systematic review and meta-analysis of the effectiveness of sorafenib over other targeted agents.Adherence to Guidelines among Italian Urologists on Imaging Preoperative Staging of Low-Risk Prostate Cancer: Results from the MIRROR (Multicenter Italian Report on Radical Prostatectomy Outcomes and Research) Study.Modified Glasgow Prognostic Score is Associated With Risk of Recurrence in Bladder Cancer Patients After Radical Cystectomy: A Multicenter Experience.Salvage image-guided intensity modulated or stereotactic body reirradiation of local recurrence of prostate cancer.Increased Expression of the Autocrine Motility Factor is Associated With Poor Prognosis in Patients With Clear Cell-Renal Cell Carcinoma.Cancer of the prostate.Urinary long noncoding RNAs in nonmuscle-invasive bladder cancer: new architects in cancer prognostic biomarkers.Third-Line Chemotherapy for Metastatic Urothelial Cancer: A Retrospective Observational Study.In vitro synergistic cytotoxicity of gemcitabine and pemetrexed and pharmacogenetic evaluation of response to gemcitabine in bladder cancer patients.European Study of Radical Prostatectomy: time trends in Europe, 1993-2005.Bladder preservation in non-metastatic muscle-invasive bladder cancer (MIBC): a single-institution experienceLong non-coding RNA containing ultraconserved genomic region 8 promotes bladder cancer tumorigenesis.External validation of EORTC risk scores to predict recurrence after transurethral resection of brazilian patients with non -muscle invasive bladder cancer stages Ta and T1.Rationale and protocol of AIRC IG-13218, short-term radiotherapy for early prostate cancer with concomitant boost to the dominant lesion.Urotensin II receptor on preoperative biopsy is associated with upstaging and upgrading in prostate cancer.Serum metabolomics can predict the outcome of first systematic transrectal prostate biopsy in patients with PSA <10 ng/ml.Biomarkers in localized prostate cancer.High-Risk Prostate Cancer and Radiotherapy: The Past and the Future. A Benchmark for a New Mixed Beam Radiotherapy Approach.The emerging role of obesity, diet and lipid metabolism in prostate cancer.The stress hormone norepinephrine increases migration of prostate cancer cells in vitro and in vivo.Primary focal prostate radiotherapy: Do all patients really need whole-prostate irradiation?Do we need new high-risk criteria for surgically treated renal cancer patients to improve the outcome of future clinical trials in the adjuvant setting? Results of a comprehensive analysis based on the multicenter CORONA database.The evolving role of monoclonal antibodies in the treatment of patients with advanced renal cell carcinoma: a systematic review.Reliability of Frozen Section Examination in a Large Cohort of Testicular Masses: What Did We Learn?Multiparametric magnetic resonance imaging and frozen-section analysis efficiently predict upgrading, upstaging, and extraprostatic extension in patients undergoing nerve-sparing robotic-assisted radical prostatectomy.Robot-Assisted Vesico-Vaginal Fistula Repair: Our Technique and Review of the Literature.Linac-based stereotactic body radiotherapy for oligometastatic patients with single abdominal lymph node recurrent cancer.Role of Multi-Parametric Magnetic Resonance Image and PIRADS Score in Patients with Prostate Cancer Eligible for Active Surveillance According PRIAS Criteria.Results of a Randomised Controlled Trial Comparing Intravesical Chemohyperthermia with Mitomycin C Versus Bacillus Calmette-Guérin for Adjuvant Treatment of Patients with Intermediate- and High-risk Non-Muscle-invasive Bladder Cancer.Salvage Stereotactic Body Radiotherapy for Isolated Lymph Node Recurrent Prostate Cancer: Single Institution Series of 94 Consecutive Patients and 124 Lymph Nodes.
P50
Q21256692-FE6D7F95-DBD8-4ECA-9BBD-3FF265EFC577Q28080936-4418D04C-5082-4948-9B99-883BA19D0128Q30315523-75D69AC9-9CD7-4CEC-8A80-1FC2AF6B695DQ31083823-F87250AE-C00A-43D1-B977-BF4835DF3D84Q33334473-DBF2D22D-9FBC-464A-9406-530AD5A5190BQ33566981-FD9DD790-F85B-4187-8BE0-C1BC319BBB5EQ34825819-E94463AC-9C30-428C-B0E5-74DB9230D8FEQ35511975-547723B1-5521-4598-A36E-D05559731FE4Q35602169-C0923094-3E31-492B-B058-7F53BAB32CD4Q35689822-F690E079-844E-4EE3-BA4F-7499C48594AAQ35906161-0417C1D0-93DA-4576-A7B1-ADEEE152AA9DQ35990762-DF887A13-916B-4006-A28E-7A411724BBE8Q36207083-6DC9BB0A-ED9F-4587-8DA1-8AD1589EE95AQ36295691-52F5192A-7D85-443A-B7EA-662AF9FDF78AQ36299355-E8786989-A625-4E3A-84D5-A0DD202148B0Q36323365-394356F4-4E37-40A4-A86D-46FF51F3C6A9Q36355609-4756ECC5-73B0-4E38-BD9D-BC18478D63B0Q36421012-F1B89031-A78F-4971-AFED-A0C74342A62AQ36612195-E34EFC4A-3466-4EBB-8C7C-9E615FAC299FQ36861743-6C4F6263-41C1-46CB-9320-8E707DFFEDBDQ37146457-9FF4FBC4-22C2-4978-B554-4654186121C5Q37190399-317C1DB5-D48A-4DFD-9C5A-321E0DF2736BQ37344341-96D093B7-C0D5-49EA-BC5B-3EB8F98DBA22Q38388976-34323C26-C978-4091-ADFC-84403BE57C46Q38588658-B3C23F95-16F2-4574-8D72-71F1BB914B2BQ38646996-44E28CDC-3260-4FC7-BD4D-66EBABBF9A30Q38697114-BB78B5B3-2F9C-40E8-A41F-E2CB61996806Q38758360-C649606B-E50B-4AD7-B5FE-D568E2902474Q38821546-7344CB49-0A41-4FFE-9636-2169F77BC816Q38865724-81062A66-B059-46EB-88AD-F05A2691A6FFQ38891639-1213D41D-DEEB-4C2C-B454-98E7277590A4Q38905219-9385119E-F4A6-407F-9CB3-E20C35478E01Q38910154-70AA936C-0FA9-4075-B5BF-464615EDB384Q38952903-0505133A-91E3-41C7-B78A-479001A10E25Q39282130-A268BADC-8B06-432D-AE2D-AAA6DADEBAEDQ39457760-4C3AA6AA-A1F8-4EFB-9D1C-7C0EC0E10FD1Q39550407-3191C566-79EF-4377-96B8-41A05C11B33DQ39863407-9616E610-3358-4746-80A7-984CB76ED9EDQ40069065-0D279301-31B7-4723-BB30-981C578C941AQ40341215-09876EE1-5C07-45B6-999A-9F6D2F0F530D
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Ottavio de Cobelli
@ast
Ottavio de Cobelli
@en
Ottavio de Cobelli
@es
Ottavio de Cobelli
@nl
type
label
Ottavio de Cobelli
@ast
Ottavio de Cobelli
@en
Ottavio de Cobelli
@es
Ottavio de Cobelli
@nl
prefLabel
Ottavio de Cobelli
@ast
Ottavio de Cobelli
@en
Ottavio de Cobelli
@es
Ottavio de Cobelli
@nl
P106
P1153
6701376562
P31
P496
0000-0002-0699-8620